Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Antibacterials

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Almangour TA, et al. Ceftazidime-avibactam for the Treatment of Multidrug-resistant Pseudomonas aeruginosa Central Nervous System Infection in Pediatric Patient: A Case Report. Pediatric Infectious Disease Journal 41: 436-438, No. 5, May 2022. Available from: URL: http://doi.org/10.1097/INF.0000000000003439 Almangour TA, et al. Ceftazidime-avibactam for the Treatment of Multidrug-resistant Pseudomonas aeruginosa Central Nervous System Infection in Pediatric Patient: A Case Report. Pediatric Infectious Disease Journal 41: 436-438, No. 5, May 2022. Available from: URL: http://​doi.​org/​10.​1097/​INF.​0000000000003439​
Metadaten
Titel
Antibacterials
Lack of efficacy: case report
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-14442-2

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Pamidronic acid

Case report

Prednisone

Case report

Multiple drugs

Case report

Irinotecan